Óêðà¿íñüêèé íàóêîâî-ìåäè÷íèé ìîëîä³aeíèé aeóðíàë 67 Ê˲Ͳ×ÍÀ ÌÅÄÈÖÈÍÀ / CLINICAL MEDICINE Âñòóï. ßê³ñòü aeèòòÿ (ßAE)-öå ñòóï³íü êîìôîðòíîñò³ ëþäèíè, ÿê óñåðåäèí³ ñåáå, òàê ³ â ðàìêàõ ñâîãî ñóñï³ëü-ñòâà [3]. Òàêà îö³íêà ïîâí³ñòþ çàëåaeèòü â³ä ô³çè÷íîãî ³ ïñèõîåìîö³éíîãî ñòàíó, ð³âíÿ íåçàëåaeíîñò³, ñóñï³ëüíîãî ñòàíîâèùà, âïëèâó íàâêîëèøíüîãî ñåðåäîâèùà ³ îñîáèñ-òèõ óÿâëåíü ³íäèâ³äóóìà. îñíîâ³ åôåêòèâíîñò³ ë³êóâàííÿ õâîðèõ íåçàëåaeíî â³ä ïàòîëî㳿 ëåaeèòü ïîêðàùàííÿ ïîêàç-íèê³â ÿêîñò³ aeèòòÿ. ×åðåç òå

more »

... éîãî îö³íþâàííþ â îñòàíí³ ðîêè ïðèä³ëÿºòüñÿ ðåòåëüíà óâàãà [5]. Ìåòîþ äîñë³äaeåííÿ ñòàëî âèâ÷åííÿ ðîë³ çâ'ÿçêó ³íäèâ³äóàëüíèõ îñîáëèâîñòåé õâîðîãî ç ïåðåá³ãîì õðîí³÷íîãî îáñòðóêòèâíîãî çàõâîðþâàííÿ ëåãåíü (ÕÎÇË) íà òë³ ñóïóòíüîãî õðîí³÷íîãî ïàíêðåàòèòó (ÕÏ) òà âïëèâ êîìïëåêñíîãî ë³êóâàííÿ ³ç äîäàâàííÿì åñåíö³àëüíèõ ôîñôîë³ï³ä³â òà á³îôëàâîíî¿ä³â íà äîñë³äaeóâàí³ ïîêàçíèêè. Ìàòåð³àëè ³ ìåòîäè. Äîñë³äaeåííÿ ïðîâåäåí³ ó 56 õâî-ðèõ íà ÕÎÇË Â-Ñ ãðóï, ó ÿêèõ ñòóï³íü îáñòðóêö³¿ â³äïîâ³-äàâ GOLD 1-2 ç íèçüêèì ðèçèêîì ³ á³ëüø âèðàaeåíîþ ñèì-ïòîìàòèêîþ (Â), à òàêîae GOLD 3 ç âèñîêèì ðèçèêîì, àëå ìåíø âèðàaeåíîþ ñèìïòîìàòèêîþ (Ñ),-² ãðóïà, 60 õâî-ðèõ íà ÕÎÇË ç â³äïîâ³äíîþ õàðàêòåðèñòèêîþ ãðóï ³ç ñó-ïóòí³ì ÕÏ (²² ãðóïà) òà 19 ïðàêòè÷íî çäîðîâèõ îñ³á â ÿêîñò³ ðåôåðåíòíî¿ ãðóïè. Äëÿ âèâ÷åííÿ ÿêîñò³ aeèòòÿ âè-ÓÄÊ 616.24-007.271:616.37-002.2 ÂÏËÈ "ÅÑÅÍÖ²À˪ ÔÎÐÒÅ Í" ÒÀ ÊÂÅÐÖÅÒÈÍÓ ÍÀ ÏÎÊÀÇÍÈÊÈ ßÊÎÑÒ² AEÈÒÒß ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ ²Ç ÑÓÏÓÒÍ²Ì ÕÐÎͲ×ÍÈÌ ÏÀÍÊÐÅÀÒÈÒÎÌ Çàõàðóê Õ.Ì., Ïåòðèê ².Â., Ãàøîê Â.Â., Òåëåê³ ß.Ì. Áóêîâèíñüêèé äåðaeàâíèé ìåäè÷íèé óí³âåðñèòåò, ì. ×åðí³âö³, Óêðà¿íà Êëþ÷îâ³ ñëîâà: ÿê³ñòü aeèòòÿ, õðîí³÷íå îáñòðóêòèâíå çàõâîðþâàííÿ ëåãåíü, õðîí³÷íèé ïàíêðåàòèò, ë³êóâàííÿ. Summary. A study of the quality of life of patients with chronic obstructive pulmonary disease in the presence of chronic pancreatitis was performed. The impact of integrated treatment with essential phospholipids and bioflavonoids on the quality of life of patients with comorbidity was analyzed.